Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina <i>et al</i>.

Duret, Pierre-Marie; Spielmann, Lionel; Messer, Laurent

Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al.

Duret, Pierre-Marie; Spielmann, Lionel; Messer, Laurent.

Duret PM; Service de Rhumatologie, Hôpitaux Civils de Colmar, Colmar, Alsace, France pierremarie.duret@gmail.com.
Spielmann L; Service de Rhumatologie, Hôpitaux Civils de Colmar, Colmar, Alsace, France.
Messer L; Service de Rhumatologie, Hôpitaux Civils de Colmar, Colmar, Alsace, France.

Ann Rheum Dis ; 80(5): e80, 2021 05.

Article in English | MEDLINE | ID: covidwho-1180927

Subject(s)

Antirheumatic Agents; Arthritis, Psoriatic; COVID-19; Spondylarthritis; Antirheumatic Agents/therapeutic use; Arthritis, Psoriatic/drug therapy; Etanercept/therapeutic use; Humans; SARS-CoV-2; Spondylarthritis/drug therapy; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Ustekinumab/therapeutic use

Keywords

ankylosing; antirheumatic agents; arthritis; biological therapy; infectious; rheumatoid; spondylitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Psoriatic / Antirheumatic Agents / Spondylarthritis / COVID-19 Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-218147

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google